An ApoE-Aβ inhibition complex in Aβ fibril extension

Chemistry and Biology

Volumn 3, Issue 11, 1996, Pages 949-956

  Wood, Stephen J ^a   Chan, Winnie ^a   Wetzel, Ronald ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Temple University   (United States)

Author keywords

Alzheimer's disease; amyloid; apolipoprotein; nucleation; seeding

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; RECOMBINANT PROTEIN;

ARTICLE; METABOLISM;

AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; RECOMBINANT PROTEINS;

EID: 0030299790     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90183-0     Document Type: Article

References (41)

1. Corder, E.H., et al., & Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
2. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. & Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res. 541, 163-166.
3. Wisniewski, T. & Frangione, B. (1992). Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-338.
4. Naslund, J., et al., & Nordstedt, C. (1995). Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 15, 219-228.
5. Price, D.L. & Sisodia, S.S. (1994). Cellular and molecular biology of Alzheimer's disease and animal models. Ann. Rev. Medicine 45, 435-446.
6. Coria, F., Rubio, I., & Bayon, C. (1994). Alzheimer's disease, β-amyloidosis, and aging. Rev. Neurosci. 5, 275-292.
7. Garlepp, M.J., Tabarias, H., van, B.F., Zilko, P.J., Laing, B. & Mastaglia, F.L. (1995). Apolipoprotein E ∈4 in inclusion body myositis. Ann. Neurol. 38, 957-959.
8. Greenberg, S.M., Rebeck, G.W., Vonsattel, J.P., Gomez, I.T. & Hyman, B.T. (1995). Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38, 254-259.
9. Premkumar, D.R., Cohen, D.L., Hedera, P., Friedland, R.P. & Kalaria, R.N. (1996). Apolipoprotein E-∈4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148, 2083-2095.
10. Ohm, T.G., Kirca, M., Bohl, J., Scharnagl, H., Gross, W. & Marz, W. (1995). Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66, 533-587.
11. Strittmatter, W.J., et al., & Roses, A.D. (1993). Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
12. Strittmatter, W.J., et al., & Roses, A.D. (1993). Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
13. Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J. & Frangione, B. (1993). Apolipoprotein E: binding to soluble Alzheimer's β amyloid. Biochem. Biophys. Res. Commun. 192, 359-365.
14. Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T. & Frangione, B. (1994). Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Amer. J. Path. 145, 1030-1035.
15. Sanan, D.A., et al., & Strittmatter, W.J. (1994). Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860-869.
16. Ma, J., Yee, A., Brewer, H.J., Das, S. & Potter, H. (1994). Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
17. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. & Frail, D.E. (1994). Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403-23406.
18. Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H. & Lansbury, P.T., Jr. (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 763-767.
19. Castano, E.M., et al., & Frangione, B. (1995). Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306, 599-604.
20. LaDu, M.J., Pederson, T.M., Frail, D.E., Reardon, C.A., Getz, G.S. & Falduto, M.T. (1995). Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039-9042.
21. Chan, W., Fornwald, J., Brawner, M. & Wetzel, R. (1996). Native complex formation between ApoE isoforms and the Alzheimer's disease peptide Aβ. Biochem. 35, 7123-7130.
22. Wood, S.J., Chan, W. & Wetzel, R. (1996). Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochem. 35, 12623-12628.
23. Wetzel, R. (1996). For protein misassembly, it's the 'I' decade. Cell 86, 699-702.
24. Wetzel, R. (1997). The role of accessory proteins in protein folding diseases. In molecular chaperones in proteins: structure, function, and mode of action. (Fink, A. & Goto, Y., eds), Marcel Dekker, New York, in press.
25. Wood, S.J., Mackenzie, L., Maleeff, B., Hurle, M.R. & Wetzel, R. (1996). Selective inhibition of βA4 fibril formation. J. Biol. Chem. 271, 4086-4092.
26. Wood, S.J., Maleeff, B., Hart, T. & Wetzel, R. (1996), Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's peptide Aβ. J. Mol. Biol. 256, 870-877.
27. Mulkerrin, M.G. & Wetzel, R. (1989). pH dependence of the reversible and irreversible thermal denaturation of γ interferons. Biochemistry 28, 6556-6561.
28. Howlett, D.R., et al., & Roberts, G.W. (1995). Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration 4, 23-32.
29. Shuvaev, V.V. & Siest, G. (1996). Interaction between human amphipathic apolipoproteins and amyloid β-peptide: surface plasmon resonance studies. FEBS Lett. 383, 9-12.
30. Blake, C. & Serpell, L. (1996). Synchrotron X-ray studies suggest that the core of the transthyretin amyloid is a continuous β-sheet helix. Structure 4, 989-998.
31. Jarrett, J.T. & Lansbury, P.J. (1992). Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31, 12346-12352.
32. Jarrett, J.T. & Lansbury, P.J. (1993), Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie. Cell 73, 1055-1058.
33. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. (1993), Neurodegeneration induced by β-amyloid peptides in vivo: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
34. Davis-Salinas, J. & Van Nostrand, W.E. (1995). Amyloid β-protein aggregation nullifies its pathologic propertiess in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270, 20887-20890.
35. Janciauskiene, S., Garcia, D.E., Frutos, P, Carlemalm, E., Dahlback, B. & Eriksson, S. (1995). Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component. J. Biol. Chem. 270, 26041-26044.
36. Han, H., Weinreb, P.H. & Lansbury, P.T. (1996). The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chemistry & Biology 2, 163-169.
37. Monteilhet, C., Lachacinski, N. & Aggerbeck, L.P. (1993). Cytoplasmic and periplasmic production of human apolipoprotein E in Escherichia coli using natural and bacterial signal peptides. Gene 125, 223-228.
38. Naiki, H., Higuchi, K., Hosokawa, M. & Takeda, T. (1989). Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal. Biochem. 177, 244-249.
39. Klunk, W.E., Pettegrew, J.W. & Abraham, D.J. (1989). Quantitative evaluation of Congo Red binding to amyloid-like proteins with a β-pleated sheet conformation. J. Histochem. Cytochem. 37, 1273-1281.
40. Johnsson, B., Lofas, S. & Lindqvist, G. (1991). Immobilization of proteins to a carboxymethyldextran modified gold surface for biospecific interaction analysis in surface plasmon resonance. Anal. Biochem. 198, 268-277.
41. Maimqvist, M. (1993). Biospecific interaction analysis using biosensor technology. Nature 361, 186-187.